Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation
- 20 April 2021
- journal article
- review article
- Published by Springer Nature in Pharmacological Reports
- Vol. 73 (4) , 1079-1095
Abstract
G-protein-coupled receptors (GPCRs) have an enormous biochemical importance as they bind to diverse extracellular ligands and regulate a variety of physiological and pathological responses. G-protein activation measures the functional consequence of receptor occupancy at one of the earliest receptor-mediated events. Receptor coupling to G-proteins promotes the GDP/GTP exchange on Gα subunits. Thus, modulation of the binding of the poorly hydrolysable GTP analog [35S]GTPγS to the Gα-protein subunit can be used as a functional approach to quantify GPCR interaction with agonist, antagonist or inverse agonist drugs. In order to determine receptor-mediated selective activation of the different Gα-proteins, [35S]GTPγS binding assays combined with immunodetection by specific antibodies have been developed and applied to physiological and pathological brain conditions. Currently, immunoprecipitation with magnetic beads and scintillation proximity assays are the most habitual techniques for this purpose. The present review summarizes the different procedures, advantages and limitations of the [35S]GTPγS binding assays combined with selective Gα-protein sequestration methods. Experience of functional coupling of several GPCRs to different Gα-proteins and recommendations for optimal performance in brain membranes are described. One of the biggest opportunities opened by these techniques is that they enable evaluation of biased agonism in the native tissue, which results in high interest in drug discovery. The available results derived from application of these functional methodologies to study GPCR dysfunctions in neuro-psychiatric disorders are also described. In conclusion, [35S]GTPγS binding combined with antibody-mediated immunodetection represents an useful method to separately evaluate the functional activity of drugs acting on GPCRs over each Gα-protein subtype.Keywords
Funding Information
- Eusko Jaurlaritza (IT1211/19, KK-2019/00049)
- Spanish State Research Agency and EDR Funds (SAF2017-88126R)
This publication has 101 references indexed in Scilit:
- Efficacy and ligand bias at the μ‐opioid receptorBritish Journal of Pharmacology, 2013
- Development of the mammalian axial skeleton requires signaling through the Gα i subfamily of heterotrimeric G proteinsProceedings of the National Academy of Sciences, 2012
- Mathematical Models for Quantitative Assessment of Bioluminescence Resonance Energy Transfer: Application to Seven Transmembrane Receptors OligomerizationFrontiers in Endocrinology, 2012
- Muscarinic acetylcholine receptor-mediated activation of Gq in rat brain membranes determined by guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assayJournal of Neural Transmission, 2011
- Structural basis for the specific inhibition of heterotrimeric G q protein by a small moleculeProceedings of the National Academy of Sciences, 2010
- Anatomical Profiling of G Protein-Coupled Receptor ExpressionCell, 2008
- A Novel Gαq/11-selective InhibitorJournal of Biological Chemistry, 2004
- The [35S]GTPγS binding assay: approaches and applications in pharmacologyLife Sciences, 2003
- Effects of Age, Postmortem Delay and Storage Time on Receptor-mediated Activation of G-proteins in Human BrainNeuropsychopharmacology, 2002
- Receptor‐Mediated Activation of G Proteins Is Increased in Postmortem Brains of Bipolar Affective Disorder SubjectsJournal of Neurochemistry, 1996